approaches. [3] [4] [5] [6] Subsequent data from independent groups, however, have shown more limited success. [7] [8] [9] One factor that may impact success is rigorous identification and targeting of stable rotor activity.
In this study, we investigated whether a protocolized approach to identify temperospatially stable rotors by sequential FIRM mapping, when compared to a physician-preference approach, would improve acute and intermediate-term outcomes in patients undergoing FIRMguided ablation and PVI for persistent AF.
2 | METHODS
| Study population
Patients who underwent clinically indicated AF ablation with PVI plus FIRM-guided rotor ablation at our institution during 2 periods in 2015 (February-April and September-December) were included in the study through serial enrollment into initial and protocolized cohorts; patients were not randomized. All patients provided written informed consent, and the study was approved by The Johns Hopkins
Hospital institutional review board.
| Procedural details
Briefly, patients were brought into the electrophysiology laboratory and placed under general anesthesia. A transesophageal echocardiogram was performed at the discretion of the operator. A 3-dimensional bi-atrial map was constructed with an electroanatomic mapping system (CARTO; Biosense Webster, South Diamond Bar, CA) and was merged onto a preexisting atrial computed tomography (CT) or magnetic resonance imaging (MRI). AF was induced in patients presenting in sinus rhythm by atrial burst pacing and isoproterenol infusion. Reference catheters were placed in the superior vena cava and coronary sinus.
Rotor mapping was performed with a 64-pole basket mapping catheter (FIRMap; Abbott, Chicago, IL) of the appropriate size positioned in the right and the left atrium, with care taken to optimize electrode-tissue contact ( Figure 1A ,B). Anticoagulation with heparin was performed for a target activated clotting time of >350 seconds.
Unipolar electrograms were recorded and exported for processing on the commercially available Topera system (Rhythm View; Topera Medical, Menlo Park, CA). Rotors were identified (see Mapping approaches below), projected onto the CARTO electroanatomical map ( Figure 1C) , and ablated.
Once rotor elimination was achieved in both atria, conventional PVI was performed as previously reported. Briefly, wide-area circumferential lesion sets were delivered, with electrical PV isolation demonstrated with lasso-catheter mapping. Ablation (rotor and PVI)
was performed with a 4-mm, irrigated, force-sensing ablation catheter, with 25 to 30 W (posterior LA) and 30 to 40 W (nonposterior LA)
power delivery and goal contact force of 10 to 30g.
| Mapping approaches
Patients in the first cohort (n = 15) underwent FIRM-guided rotor ablation and PVI at the discretion of the operator, without predefined Abbreviations: AF, atrial fibrillation; BMI, body mass index; CAD, coronary artery disease; CHA2DS2VASC, congestive heart failure, hypertension, age ≥75 years, diabetes mellitus, stroke, vascular disease, age 65-74 years, sex category; CHF, congestive heart failure; LA, left atrium; LVEF, left ventricular ejection fraction; OSA, obstructive sleep apnea; RA, right atrium; RF, radiofrequency. P = 0.56). Similarly, repeat procedure rate (60% vs 41.7%, P = 0.45) and LA size in centimeters (4.8 AE 0.9 vs 4.5 AE 0.7, P = 0.50) did not have any statistically significant difference. Only left ventricular ejection fraction percentage was lower in group 2 and was statistically significant (56.9 AE 2.5 vs 48.7 AE 8.7, P = 0.005).
Procedure time, fluoroscopy time, and ablation time did not differ between the 2 groups. In both groups, the majority of patients underwent cardioversion to normal sinus rhythm (NSR) (86.7% vs 75%, , with no differences in RA and LA rotor areas. The rotor area comprised 1.2% AE 0.8% of total RA surface area, and 1.7% AE 0.8% of total LA surface area.
| Temporal stability and acute rhythm changes
Of the patients assessed by protocolized mapping to determine temperospatial rotor stability, 10 out of 12 patients showed reproducibility in at least 1 atrium on a minimum of 2 out of 3 consecutive maps.
In these 10 patients, a total of 33 stable rotors (mean, comparing patients with acute procedural change in rhythm to those without, sinus rhythm on presentation (62.5% vs 15.8%, P = 0.03), higher number of targeted rotors in LA (2.8 AE 1.2 vs 1.5 AE 1.0, P = 0.01), and higher total targeted rotors (3.8 AE 1.7 vs 2.5 AE 1.0, P = 0.02) were statistically significant on univariable analysis (Table 2 ).
| Ablation outcomes
All patients had successful rotor elimination and PVI at the conclusion of the case. There were no procedure-related complications reported in any patients. Early recurrence of AF/AT during the blanking period occurred in 9 (33.3%) patients, including 6 out of 15 (40%) in the first and 3 out of 12 (25%) in the second cohort. All patients were assessed 
| DISCUSSION
In the current investigation, we report our initial experience with FIRM mapping and ablation of AF-sustaining rotors in patients undergoing PVI. Our report is notable for 3 principle findings:
(1) Establishing a protocol for identification of temperospatially stable rotors and for predetermined outcomes of ablation had no appreciable effect on acute or intermediate-term procedure success.
(2) Targeting increased numbers of rotors correlated with acute change in rhythm. (3) Short-term outcomes at 6 months in this cohort was acceptable; however, longer follow-up is needed to assess the true utility of this modality. Abbreviations: AF, atrial fibrillation; BMI, body mass index; CAD, coronary artery disease; CHA2DS2VASC, congestive heart failure, hypertension, age ≥75 years, diabetes mellitus, stroke, vascular disease, age 65-74 years, sex category; CHF, congestive heart failure; LA, left atrium; LVEF, left ventricular ejection fraction; OSA, obstructive sleep apnea; RA, right atrium; RF, radiofrequency.
| Rationale of formalized approach
Early reports assessing the utility of rotor mapping and ablation as an adjunctive or even an alternative strategy to PVI alone for AF patients have been encouraging. [3] [4] [5] [6] Those positive results have not been reproduced in other investigations, [7] [8] [9] however, leading to impassioned public debates about the utility of rotor mapping and ablation. 10, 11 Because a theme in this debate involves proper use of the basket catheter and mapping system for identification of stable or precessing rotors, 12 we sought to take advantage of 2 trial periods with the Topera system. During the first epoch of Topera use, physicians were free to use the system at their discretion. During the second epoch, a uniform mapping protocol designed to identify stable rotor activity was adopted, as were standardized ablation outcomes (elimination of rotor activity with subsequent mapping). Our study was informed in part by the observation that in recurrent AF, organized sources have been suggested to be spatially stable over a time period of 1 to 2 years, and if these sources are carefully identified on initial ablation, this may lead to improved outcomes. 13 Operators were the same during both phases of our study, and all are experienced ablationists; care was taken throughout to choose appropriately sized mapping basket catheters, and to use imaging liberally to ensure optimal basket positioning.
| Outcomes
Despite these efforts, we had disappointing results. We found that in 
| Limitations
The principle limitation of this observational study is small sample size and lack of a control group. Outcomes may be impacted by selection bias, with FIRM mapping reserved for sicker patients not representative of the general patient population referred for AF ablation. Finally, operator variability may have played a role in outcomes, though this was addressed explicitly as much as possible through protocolization.
| CONCLUSION
Focal impulse and rotor modulation-guided ablation in addition to PVI had unfavorable short-term outcomes in our cohort of sicker patients, but longer follow-up is needed to fully assess its utility.
Acute change in rhythm was achieved more often with a higher number of ablated rotors and in patients presenting in sinus rhythm. Protocolization to identify temperospatially stable rotors did not have an appreciable impact in short-and intermediate-term outcomes.
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